Business Context and Reporting Period
This Form 8-K is a current report filed by GlycoMimetics, Inc. (trading symbol: GLYC) on June 21, 2024. The filing addresses a regulatory notice received from The Nasdaq Stock Market regarding the company's compliance with listing standards.
Key Financial Metrics
The filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on the status of the company's stock price relative to Nasdaq listing requirements.
Material Changes
The material event reported is the receipt of a notice of noncompliance with Nasdaq Listing Rule 5450(a)(1). The company's common stock minimum bid price has remained below $1.00 per share for 30 consecutive business days. This noncompliance has no immediate effect on the listing or trading of the stock.
Outlook, Risks, and Management Commentary
- Compliance Timeline: The company has a 180-calendar day grace period, ending December 18, 2024, to regain compliance.
- Compliance Requirement: To regain compliance, the minimum bid price must meet or exceed $1.00 per share for a minimum of ten consecutive business days within the grace period.
- Alternative Options: If the company fails to regain compliance by December 18, 2024, it may be eligible for an additional 180-day period if it elects to transfer to The Nasdaq Capital Market, provided it meets other listing standards (excluding the bid price requirement).
- Risks: Failure to regain compliance during the applicable periods could result in delisting. Management states there can be no assurance that the company will be able to regain compliance.
- Management Action: The company intends to actively monitor the bid price and consider available options to regain compliance.
Investor Verification Checklist
- Verify the current trading price of GLYC to assess the likelihood of meeting the $1.00 threshold.
- Monitor for any announcements regarding a reverse stock split or other corporate actions intended to increase the share price.
- Check for any subsequent filings regarding the company's intent to transfer to The Nasdaq Capital Market if the initial grace period expires.
- Review the company's most recent 10-K or 10-Q for financial health context, as this 8-K contains no financial statements.